These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

391 related articles for article (PubMed ID: 22940555)

  • 21. Developmental Outcomes of Aicardi Goutières Syndrome.
    Adang L; Gavazzi F; De Simone M; Fazzi E; Galli J; Koh J; Kramer-Golinkoff J; De Giorgis V; Orcesi S; Peer K; Ulrick N; Woidill S; Shults J; Vanderver A
    J Child Neurol; 2020 Jan; 35(1):7-16. PubMed ID: 31559893
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Epilepsy in Aicardi-Goutières syndrome.
    Ramantani G; Maillard LG; Bast T; Husain RA; Niggemann P; Kohlhase J; Hertzberg C; Ungerath K; Innes MA; Walkenhorst H; Bevot A; von Stülpnagel C; Thomas K; Niemann F; Ergun MA; Tacke U; Häusler M; Ikonomidou C; Korinthenberg R; Lee-Kirsch MA
    Eur J Paediatr Neurol; 2014 Jan; 18(1):30-7. PubMed ID: 24011626
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Aicardi-Goutières syndrome: a model disease for systemic autoimmunity.
    Lee-Kirsch MA; Wolf C; Günther C
    Clin Exp Immunol; 2014 Jan; 175(1):17-24. PubMed ID: 23786362
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Mouse models for Aicardi-Goutières syndrome provide clues to the molecular pathogenesis of systemic autoimmunity.
    Behrendt R; Roers A
    Clin Exp Immunol; 2014 Jan; 175(1):9-16. PubMed ID: 23713592
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Inhibition of the de-myelinating properties of Aicardi-Goutières syndrome lymphocytes by cathepsin D silencing.
    Pulliero A; Marengo B; Longobardi M; Fazzi E; Orcesi S; Olivieri I; Cereda C; Domenicotti C; Balottin U; Izzotti A
    Biochem Biophys Res Commun; 2013 Jan; 430(3):957-62. PubMed ID: 23261460
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Heterozygous TREX1 p.Asp18Asn mutation can cause variable neurological symptoms in a family with Aicardi-Goutieres syndrome/familial chilblain lupus.
    Abe J; Izawa K; Nishikomori R; Awaya T; Kawai T; Yasumi T; Hiragi N; Hiragi T; Ohshima Y; Heike T
    Rheumatology (Oxford); 2013 Feb; 52(2):406-8. PubMed ID: 22829693
    [No Abstract]   [Full Text] [Related]  

  • 27. Aicardi-Goutières syndrome-associated mutation at ADAR1 gene locus activates innate immune response in mouse brain.
    Guo X; Wiley CA; Steinman RA; Sheng Y; Ji B; Wang J; Zhang L; Wang T; Zenatai M; Billiar TR; Wang Q
    J Neuroinflammation; 2021 Jul; 18(1):169. PubMed ID: 34332594
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A nationwide survey of Aicardi-Goutières syndrome patients identifies a strong association between dominant TREX1 mutations and chilblain lesions: Japanese cohort study.
    Abe J; Nakamura K; Nishikomori R; Kato M; Mitsuiki N; Izawa K; Awaya T; Kawai T; Yasumi T; Toyoshima I; Hasegawa K; Ohshima Y; Hiragi T; Sasahara Y; Suzuki Y; Kikuchi M; Osaka H; Ohya T; Ninomiya S; Fujikawa S; Akasaka M; Iwata N; Kawakita A; Funatsuka M; Shintaku H; Ohara O; Ichinose H; Heike T
    Rheumatology (Oxford); 2014 Mar; 53(3):448-58. PubMed ID: 24300241
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Neuropathological Findings in a Case of
    Gilani A; Adang LA; Vanderver A; Collins A; Kleinschmidt-DeMasters BK
    Pediatr Dev Pathol; 2019; 22(6):566-570. PubMed ID: 30952201
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Sine causa tetraparesis: A pilot study on its possible relationship with interferon signature analysis and Aicardi Goutières syndrome related genes analysis.
    Galli J; Gavazzi F; De Simone M; Giliani S; Garau J; Valente M; Vairo D; Cattalini M; Mortilla M; Andreoli L; Badolato R; Bianchi M; Carabellese N; Cereda C; Ferraro R; Facchetti F; Fredi M; Gualdi G; Lorenzi L; Meini A; Orcesi S; Tincani A; Zanola A; Rice G; Fazzi E;
    Medicine (Baltimore); 2018 Dec; 97(52):e13893. PubMed ID: 30593198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Aicardi-Goutières syndrome: a description of 21 new cases and a comparison with the literature.
    Lanzi G; Fazzi E; D'Arrigo S
    Eur J Paediatr Neurol; 2002; 6 Suppl A():A9-22; discussion A23-5, A77-86. PubMed ID: 12365365
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Neonatal detection of Aicardi Goutières Syndrome by increased C26:0 lysophosphatidylcholine and interferon signature on newborn screening blood spots.
    Armangue T; Orsini JJ; Takanohashi A; Gavazzi F; Conant A; Ulrick N; Morrissey MA; Nahhas N; Helman G; Gordish-Dressman H; Orcesi S; Tonduti D; Stutterd C; van Haren K; Toro C; Iglesias AD; van der Knaap MS; Goldbach Mansky R; Moser AB; Jones RO; Vanderver A
    Mol Genet Metab; 2017 Nov; 122(3):134-139. PubMed ID: 28739201
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Child Neurology: Aicardi-Goutières Syndrome Presenting as Recurrent Ischemic Stroke.
    Kuang SY; Li Y; Yang SL; Han X
    Neurology; 2022 Aug; 99(9):393-398. PubMed ID: 35803721
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Systemic complications of Aicardi Goutières syndrome using real-world data.
    Peixoto de Barcelos I; Jan AK; Modesti N; Woidill S; Gavazzi F; Isaacs D; D'Aiello R; Sevagamoorthy A; Charlton L; Pizzino A; Schmidt J; van Haren K; Keller S; Eichler F; Emrick LT; Fraser JL; Shults J; Vanderver A; Adang LA
    Mol Genet Metab; 2024; 143(1-2):108578. PubMed ID: 39332260
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Aicardi-Goutières syndrome: A monogenic type I interferonopathy.
    Liu A; Ying S
    Scand J Immunol; 2023 Oct; 98(4):e13314. PubMed ID: 37515439
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Aicardi-Goutieres syndrome due to mutation of the IFIH1 gene with pontine involvement. A case report].
    Florido-Rodriguez A; Eiris-Punal J; Barros-Angueira F; Toledo-Bravo de Laguna L; Santana-Artiles A; Sebastian-Garcia I; Santana-Rodriguez A; Cabrera-Lopez JC
    Rev Neurol; 2016 Oct; 63(7):309-14. PubMed ID: 27658362
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Combination of exome sequencing and immune testing confirms Aicardi-Goutières syndrome type 5 in a challenging pediatric neurology case.
    Haskell GT; Mori M; Powell C; Amrhein TJ; Rice GI; Bailey L; Strande N; Weck KE; Evans JP; Berg JS; Kishnani P
    Cold Spring Harb Mol Case Stud; 2018 Oct; 4(5):. PubMed ID: 30275001
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Spastic paraparesis and marked improvement of leukoencephalopathy in Aicardi-Goutières syndrome.
    La Piana R; Tran LT; Guerrero K; Brais B; Levesque S; Sébire G; Riou E; Bernard G
    Neuropediatrics; 2014 Dec; 45(6):406-10. PubMed ID: 25343331
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Systemic lupus erythematosus due to C1q deficiency with progressive encephalopathy, intracranial calcification and acquired moyamoya cerebral vasculopathy.
    Troedson C; Wong M; Dalby-Payne J; Wilson M; Dexter M; Rice GI; Crow YJ; Dale RC
    Lupus; 2013 May; 22(6):639-43. PubMed ID: 23651859
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Family history of autoimmune disease in patients with Aicardi-Goutières syndrome.
    Schmidt JL; Olivieri I; Vento JM; Fazzi E; Gordish-Dressman H; Orcesi S; Vanderver A
    Clin Dev Immunol; 2012; 2012():206730. PubMed ID: 23251212
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 20.